Table 2 Demographic, clinical and genetic characteristics of the individuals enrolled in the study
| Alzheimer’s disease patients (AD) |
Parkinson disease patients (PD) |
Healthy controls (HC) | |
|---|---|---|---|
| N | 10 | 10 | 10 |
| Gender (M:F) | 5:5 | 7:3 | 4:6 |
| Age (years) | 78.50 ± 5.44 | 80.22 ± 5.21 | 78.90 ± 5.95 |
| MMSE | 19.07 ± 2.51 | – | 30 |
| Y&H | – | 2.72 ± 0.94 | – |
| ApoE ε-4 carriers (%) | 50 | 40 | 20 |